DUSP26 Recombinant Protein (Human) (OPCA02463) from Aviva Systems Biology

Description

Inactivates MAPK1 and MAPK3 which leads to dephosphorylation of heat shock factor protein 4 and a reduction in its DNA-binding activity. Inhibits MAP kinase p38 by dephosphorylating it and inhibits p38-mediated apoptosis in anaplastic thyroid cancer cells. Can also induce activation of MAP kinase p38 and c-Jun N-terminal kinase (JNK)

Product Specs
ItemDUSP26 Recombinant Protein (Human) (OPCA02463)
CompanyAviva Systems Biology
Price Supplier Page View Company Product Page
Catalog NumberOPCA02463
Size25ul, 100ul
TypeProtein
FormatIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0., Liquid or Lyophilized powder
PurityGreater than 90% as determined by SDS-PAGE
Conjugate/TagN-terminal 6xHis-SUMO-tagged
Molecule NameDual specificity protein phosphatase 26
SpeciesHomo sapiens, Human
Gene Namedual specificity phosphatase 26
Molecular Weight39.9 kDa
Source/Expression SystemHuman
NCBI Gene AliasesLDP4, MKP8, SKRP3, LDP-4, MKP-8, DSP-4, NEAP, NATA1, DUSP24

Sequence

MCPGNWLWAS MTFMARFSRS SSRSPVRTRG TLEEMPTVQH PFLNVFELER LLYTGKTACN HADEVWPGLY LGDQDMANNR RELRRLGITH VLNASHSRWR GTPEAYEGLG IRYLGVEAHD SPAFDMSIHF QTAADFIHRA LSQPGGKILV HCAVGVSRSA TLVLAYLMLY HHLTLVEAIK KVKDHRGIIP NRGFLRQLLA LDRRLRQGLE A

Add to Compare List